Go to The Journal of Clinical Investigation
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Transfers
  • Advertising
  • Job board
  • Contact
  • Physician-Scientist Development
  • Current issue
  • Past issues
  • By specialty
    • COVID-19
    • Cardiology
    • Immunology
    • Metabolism
    • Nephrology
    • Oncology
    • Pulmonology
    • All ...
  • Videos
  • Collections
    • In-Press Preview
    • Resource and Technical Advances
    • Clinical Research and Public Health
    • Research Letters
    • Editorials
    • Perspectives
    • Physician-Scientist Development
    • Reviews
    • Top read articles

  • Current issue
  • Past issues
  • Specialties
  • In-Press Preview
  • Resource and Technical Advances
  • Clinical Research and Public Health
  • Research Letters
  • Editorials
  • Perspectives
  • Physician-Scientist Development
  • Reviews
  • Top read articles
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Transfers
  • Advertising
  • Job board
  • Contact
C5a impairs phagosomal maturation in the neutrophil through phosphoproteomic remodeling
Alexander J.T. Wood, Arlette M. Vassallo, Marie-Hélène Ruchaud-Sparagano, Jonathan Scott, Carmelo Zinnato, Carmen Gonzalez-Tejedo, Kamal Kishore, Clive S. D’Santos, A. John Simpson, David K. Menon, Charlotte Summers, Edwin R. Chilvers, Klaus Okkenhaug, Andrew Conway Morris
Alexander J.T. Wood, Arlette M. Vassallo, Marie-Hélène Ruchaud-Sparagano, Jonathan Scott, Carmelo Zinnato, Carmen Gonzalez-Tejedo, Kamal Kishore, Clive S. D’Santos, A. John Simpson, David K. Menon, Charlotte Summers, Edwin R. Chilvers, Klaus Okkenhaug, Andrew Conway Morris
View: Text | PDF
Research Article Immunology Infectious disease

C5a impairs phagosomal maturation in the neutrophil through phosphoproteomic remodeling

  • Text
  • PDF
Abstract

Critical illness is accompanied by the release of large amounts of the anaphylotoxin, C5a. C5a suppresses antimicrobial functions of neutrophils which is associated with adverse outcomes. The signaling pathways that mediate C5a-induced neutrophil dysfunction are incompletely understood. Healthy donor neutrophils exposed to purified C5a demonstrated a prolonged defect (7 hours) in phagocytosis of Staphylococcus aureus. Phosphoproteomic profiling of 2712 phosphoproteins identified persistent C5a signaling and selective impairment of phagosomal protein phosphorylation on exposure to S. aureus. Notable proteins included early endosomal marker ZFYVE16 and V-ATPase proton channel component ATPV1G1. An assay of phagosomal acidification demonstrated C5a-induced impairment of phagosomal acidification, which was recapitulated in neutrophils from critically ill patients. Examination of the C5a-impaired protein phosphorylation indicated a role for the PI3K VPS34 in phagosomal maturation. Inhibition of VPS34 impaired neutrophil phagosomal acidification and killing of S. aureus. This study provides a phosphoproteomic assessment of human neutrophil signaling in response to S. aureus and its disruption by C5a, identifying a defect in phagosomal maturation and mechanisms of immune failure in critical illness.

Authors

Alexander J.T. Wood, Arlette M. Vassallo, Marie-Hélène Ruchaud-Sparagano, Jonathan Scott, Carmelo Zinnato, Carmen Gonzalez-Tejedo, Kamal Kishore, Clive S. D’Santos, A. John Simpson, David K. Menon, Charlotte Summers, Edwin R. Chilvers, Klaus Okkenhaug, Andrew Conway Morris

×

Figure 6

VPS34 inhibition impairs phagosomal acidification.

Options: View larger image (or click on image) Download as PowerPoint
VPS34 inhibition impairs phagosomal acidification.
Whole blood was pretr...
Whole blood was pretreated with vehicle control or VPS34IN1 (1 μM, 60 minutes) before addition of maturation probe (5 μg/mL) (A–D), or live S. aureus (E), for 120 minutes before analysis. (A) Percentage of neutrophils that phagocytosed bioparticles. P = 0.31 by Wilcoxon’s test. n = 6 individual donors. (B) MFI of ingested particles, indicating relative quantity of phagocytosis. *P = 0.03. by Wilcoxon’s test. n = 6 individual donors. (C) pHrodo MFI, indicating phagosomal acidification. *P = 0.03. by Wilcoxon’s test. n = 6 individual donors. (D) After phagocytosis of live bacteria, human cells were lysed in alkaline dH2O and surviving bacteria were incubated overnight on blood agar. Bacterial survival was quantified by counting colonies. *P = 0.03 by paired t test, n = 5 individual donors. (E and F) Whole blood was processed as above with quantification of phagocytosis (E) and acidification (F) at the indicated time points. There was a reduction in phagosomal acidification as shown but no change in percentage of cells that underwent phagocytosis. Data are shown as mean plus or minus SD of n = 5 individual donors. **P = 0.0058 for drug treatment by 2-way repeated-measures ANOVA with Bonferroni’s multiple comparisons test.

Copyright © 2025 American Society for Clinical Investigation
ISSN 2379-3708

Sign up for email alerts